Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DYN

Dyne Therapeutics Inc

May 29 • 04:00PM ET

19.33

+0.77 4.15 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: ALMS ERAS TNGX APGE KRYS KYMR NUVL BMRN INCY RYTM

| Held by: VTI XBI IWM VB VXF VBR IBB IWN SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.23	Insider Own	20.15%	Shs Outstand	165.20M	Perf Week	11.28%
Market Cap	3.20B	Forward P/E	-	EPS next Y	-2.94	Insider Trans	-7.82%	Shs Float	132.00M	Perf Month	11.03%
Enterprise Value	2.40B	PEG	-	EPS next Q	-0.75	Inst Own	93.83%	Short Float	15.90%	Perf Quarter	23.75%
Income	-451.71M	P/S	-	EPS this Y	11.17%	Inst Trans	5.08%	Short Ratio	10.67	Perf Half Y	-7.07%
Sales	0.00M	P/B	3.69	EPS next Y	4.56%	ROA	-50.16%	Short Interest	20.98M	Perf YTD	-1.18%
Book/sh	5.24	P/C	3.29	EPS next 5Y	14.57%	ROE	-58.89%	52W High	25.00 -22.68%	Perf Year	57.92%
Cash/sh	5.88	P/FCF	-	EPS past 3/5Y	-2.41% 3.39%	ROIC	-43.91%	52W Low	8.06 139.83%	Perf 3Y	52.69%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.19% 5.38%	Perf 5Y	1.15%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	10.17%	Oper. Margin	-	ATR (14)	1.00	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	19.92	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	59.61	Recom	1.31
Dividend Gr. 3/5Y	- -	Current Ratio	19.92	EPS Q/Q	30.23%	SMA20	8.49%	Beta	1.07	Target Price	38.25
Payout	-	Debt/Eq	0.20	Sales Q/Q	-	SMA50	5.80%	Rel Volume	0.76	Prev Close	18.56
Employees	258	LT Debt/Eq	0.19	Earnings	May 11 BMO	SMA200	11.76%	Avg Volume	1.97M	Price	19.33
IPO	Sep 17, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.48% -	Trades		Volume	1,500,848	Change	4.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)